Global Oncology Drugs Market Size, Share, Growth, Trends 2020-2030: Novartis AG, Bristol-Myers Squibb Company, Merck & Co, Johnson & Johnson

Oncology Drugs Market By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Kidney Cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid Cancer, Others), By Drug Class Type, By Distribution Channel, By Route Of Administration, By Drug Classification, And By Region – Global Forecast To 2030 By The Business Research Company

The global oncology drugs market reached a value of nearly $167.9 billion in 2019, having increased at a compound annual growth rate (CAGR) of 9.8% since 2015. The market is expected to decline from $167.9 billion in 2019 to $149.9 billion in 2020 at a rate of –11%. The decline is mainly due to lockdown and social distancing norms imposed by various countries and economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is expected to grow slightly from $201.1 billion in 2021 to $284.5 billion in 2023 at a CAGR of 9.7%. The market is expected to stabilize and reach $284.5 billion in 2025 and $412.9 billion in 2030.

The key drivers of the oncology drugs market include:
Increase in Cancer Incidence Rate – The rise in the number of cancer cases across the globe is likely to contribute to the growth of the oncology drugs market during the forecast period. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for oncology drugs market over the forthcoming years.

Browse Complete Report @
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Oncology Drugs Market Segmentation:
The oncology drugs market is segmented by type of drug, by distribution channel, and by geography

By Type - The oncology drugs market can be segmented by type into drugs for
1) Blood Cancer
2) Breast Cancer
3) Lung Cancer
4) Prostate cancer
The blood cancer was the largest segment of the oncology drugs market by type, accounting for 19.0% of the total market in 2019.

By Distribution Channel – The oncology drugs market can be segmented by distribution channel into
1) Retail Pharmacies/Drug Stores
2) Hospital Pharmacies
3) Others

Request For A Sample Copy Of This Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=3440&type=smp

By Geography - The oncology drugs market is segmented into
1. North America
2. Western Europe
3. Asia Pacific
4. Eastern Europe
5. South America
6. Middle East
7. Africa

Some of the major key players involved in the oncology drugs market are
1. F. Hoffmann-La Roche AG
2. Novartis AG
3. Bristol-Myers Squibb Company
4. Merck & Co., Inc.
5. Johnson & Johnson

Place A Direct Purchase Order Of This Report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3440

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.